Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,052
archived clinical trials in
Nephrology

A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated:  12/31/1969
Childrens Health Center, PA
mi
from
Marble Falls, TX
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated: 12/31/1969
Childrens Health Center, PA
mi
from
Marble Falls, TX
Click here to add this to my saved trials
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated:  12/31/1969
Southwest Children's Research Assoicaites
mi
from
San Antonio, TX
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated: 12/31/1969
Southwest Children's Research Assoicaites
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated:  12/31/1969
Dixie Pediatrics
mi
from
Saint George, UT
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated: 12/31/1969
Dixie Pediatrics
mi
from
Saint George, UT
Click here to add this to my saved trials
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated:  12/31/1969
Next Phase Research
mi
from
Virginia Gardens, FL
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated: 12/31/1969
Next Phase Research
mi
from
Virginia Gardens, FL
Click here to add this to my saved trials
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated:  12/31/1969
Feinstein Institute for Medical Research
mi
from
Great Neck, NY
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated: 12/31/1969
Feinstein Institute for Medical Research
mi
from
Great Neck, NY
Click here to add this to my saved trials
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated:  12/31/1969
Duke University
mi
from
Durham, NC
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated: 12/31/1969
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated:  12/31/1969
Multicare Institute for Research and Innovation
mi
from
Tacoma, WA
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated: 12/31/1969
Multicare Institute for Research and Innovation
mi
from
Tacoma, WA
Click here to add this to my saved trials
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated:  12/31/1969
Pediatric Multicare West
mi
from
Lakeside, AZ
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated: 12/31/1969
Pediatric Multicare West
mi
from
Lakeside, AZ
Click here to add this to my saved trials
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated:  12/31/1969
University of Arizona
mi
from
Tucson, AZ
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated: 12/31/1969
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated:  12/31/1969
Childrens Health Care
mi
from
Wheeling, IL
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated: 12/31/1969
Childrens Health Care
mi
from
Wheeling, IL
Click here to add this to my saved trials
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated:  12/31/1969
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated: 12/31/1969
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated:  12/31/1969
Sutter Institute for Medical Research
mi
from
Roseville, CA
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated: 12/31/1969
Sutter Institute for Medical Research
mi
from
Roseville, CA
Click here to add this to my saved trials
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated:  12/31/1969
State University of New York (SUNY)
mi
from
Syracuse, NY
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated: 12/31/1969
State University of New York (SUNY)
mi
from
Syracuse, NY
Click here to add this to my saved trials
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated:  12/31/1969
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated: 12/31/1969
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated:  12/31/1969
UH Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated: 12/31/1969
UH Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Prospective Study of Microalbuminuria in Untreated Boys With Alport Syndrome
A Prospective Study of Microalbuminuria in Untreated Boys With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
A Prospective Study of Microalbuminuria in Untreated Boys With Alport Syndrome
A Prospective Study of Microalbuminuria in Untreated Boys With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Academic Medical Research Institute
mi
from
Los Angeles, CA
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Academic Medical Research Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Houston Nephrology Research
mi
from
Cypress, TX
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Houston Nephrology Research
mi
from
Cypress, TX
Click here to add this to my saved trials
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
eStudySite
mi
from
La Mesa, CA
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
eStudySite
mi
from
La Mesa, CA
Click here to add this to my saved trials
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
The Ohio State University Nephrology Clinical Trials Unit
mi
from
Columbus, OH
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
The Ohio State University Nephrology Clinical Trials Unit
mi
from
Columbus, OH
Click here to add this to my saved trials
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Nephrotex Research Group
mi
from
Dallas, TX
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Nephrotex Research Group
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Allegiance Research Specialists
mi
from
Wauwatosa, WI
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Allegiance Research Specialists
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Eminence Medical & Clinical Research
mi
from
Tampa, FL
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Eminence Medical & Clinical Research
mi
from
Tampa, FL
Click here to add this to my saved trials
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Consultants
mi
from
Kansas City, MO
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Consultants
mi
from
Kansas City, MO
Click here to add this to my saved trials
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Utah Kidney Research Institute
mi
from
Salt Lake City, UT
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Utah Kidney Research Institute
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Washington Nephrology Associates
mi
from
Alexandria, VA
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Washington Nephrology Associates
mi
from
Alexandria, VA
Click here to add this to my saved trials
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Western Nephrology
mi
from
Arvada, CO
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Western Nephrology
mi
from
Arvada, CO
Click here to add this to my saved trials
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Western Nephrology
mi
from
Westminster, CO
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Western Nephrology
mi
from
Westminster, CO
Click here to add this to my saved trials
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Apex Research of Riverside
mi
from
Riverside, CA
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Apex Research of Riverside
mi
from
Riverside, CA
Click here to add this to my saved trials
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Georgia Nephrology
mi
from
Lawrenceville, GA
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Georgia Nephrology
mi
from
Lawrenceville, GA
Click here to add this to my saved trials
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
St. Clair Nephrology
mi
from
Roseville, MI
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
St. Clair Nephrology
mi
from
Roseville, MI
Click here to add this to my saved trials
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
DaVita Clinical Research
mi
from
Minneapolis, MN
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
DaVita Clinical Research
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Kidney Medical Associates
mi
from
Bronx, NY
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Kidney Medical Associates
mi
from
Bronx, NY
Click here to add this to my saved trials
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Green and Seidner Family Practice Associates
mi
from
Lansdale, PA
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Green and Seidner Family Practice Associates
mi
from
Lansdale, PA
Click here to add this to my saved trials
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Renal Disease Research Institute
mi
from
Dallas, TX
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Renal Disease Research Institute
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
San Antonio Kidney Disease Center
mi
from
San Antonio, TX
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
San Antonio Kidney Disease Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Overlake Internal Medicine
mi
from
Bellevue, WA
Study of RG-012 in Male Subjects With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection Administered Every 2 Weeks in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Overlake Internal Medicine
mi
from
Bellevue, WA
Click here to add this to my saved trials
A Study of RG-012 in Subjects With Alport Syndrome
A Phase 1, Open-Label Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection, Including Its Effect on Renal microRNA-21, in Subjects With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Academic Medical Research Institute
mi
from
Los Angeles, CA
A Study of RG-012 in Subjects With Alport Syndrome
A Phase 1, Open-Label Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection, Including Its Effect on Renal microRNA-21, in Subjects With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Academic Medical Research Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of RG-012 in Subjects With Alport Syndrome
A Phase 1, Open-Label Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection, Including Its Effect on Renal microRNA-21, in Subjects With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Houston Nephrology Research
mi
from
Cypress, TX
A Study of RG-012 in Subjects With Alport Syndrome
A Phase 1, Open-Label Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection, Including Its Effect on Renal microRNA-21, in Subjects With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Houston Nephrology Research
mi
from
Cypress, TX
Click here to add this to my saved trials
A Study of RG-012 in Subjects With Alport Syndrome
A Phase 1, Open-Label Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection, Including Its Effect on Renal microRNA-21, in Subjects With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
eStudySite
mi
from
La Mesa, CA
A Study of RG-012 in Subjects With Alport Syndrome
A Phase 1, Open-Label Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection, Including Its Effect on Renal microRNA-21, in Subjects With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
eStudySite
mi
from
La Mesa, CA
Click here to add this to my saved trials
A Study of RG-012 in Subjects With Alport Syndrome
A Phase 1, Open-Label Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection, Including Its Effect on Renal microRNA-21, in Subjects With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Allegiance Research Specialists
mi
from
Wauwatosa, WI
A Study of RG-012 in Subjects With Alport Syndrome
A Phase 1, Open-Label Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection, Including Its Effect on Renal microRNA-21, in Subjects With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Allegiance Research Specialists
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
A Study of RG-012 in Subjects With Alport Syndrome
A Phase 1, Open-Label Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection, Including Its Effect on Renal microRNA-21, in Subjects With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Utah Kidney Research Institute
mi
from
Salt Lake City, UT
A Study of RG-012 in Subjects With Alport Syndrome
A Phase 1, Open-Label Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection, Including Its Effect on Renal microRNA-21, in Subjects With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Utah Kidney Research Institute
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of RG-012 in Subjects With Alport Syndrome
A Phase 1, Open-Label Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection, Including Its Effect on Renal microRNA-21, in Subjects With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Apex Research of Riverside
mi
from
Riverside, CA
A Study of RG-012 in Subjects With Alport Syndrome
A Phase 1, Open-Label Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection, Including Its Effect on Renal microRNA-21, in Subjects With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Apex Research of Riverside
mi
from
Riverside, CA
Click here to add this to my saved trials
A Study of RG-012 in Subjects With Alport Syndrome
A Phase 1, Open-Label Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection, Including Its Effect on Renal microRNA-21, in Subjects With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Eminence Medical & Clinical Research
mi
from
Tampa, FL
A Study of RG-012 in Subjects With Alport Syndrome
A Phase 1, Open-Label Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection, Including Its Effect on Renal microRNA-21, in Subjects With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Eminence Medical & Clinical Research
mi
from
Tampa, FL
Click here to add this to my saved trials
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated:  12/31/1969
Denver Nephrology
mi
from
Denver, CO
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated: 12/31/1969
Denver Nephrology
mi
from
Denver, CO
Click here to add this to my saved trials
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated:  12/31/1969
Boise Kidney & Hypertension, PLLC
mi
from
Caldwell, ID
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated: 12/31/1969
Boise Kidney & Hypertension, PLLC
mi
from
Caldwell, ID
Click here to add this to my saved trials
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated:  12/31/1969
Boise Kidney & Hypertension, PLLC
mi
from
Meridian, ID
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated: 12/31/1969
Boise Kidney & Hypertension, PLLC
mi
from
Meridian, ID
Click here to add this to my saved trials
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated:  12/31/1969
Clinical Research Consultants
mi
from
Kansas City, MO
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated: 12/31/1969
Clinical Research Consultants
mi
from
Kansas City, MO
Click here to add this to my saved trials